> The sad part is ofcourse the one about companies not being interested in drugs for rare diseases, even more when they're not needed frequently. I really hope we can find a solution to that.
As that'll not happen all by itself because there's less money in that, pharmaceutical companies should be legally required to spend a certain amount of their research budget on rare diseases.
A nice follow-up read regarding one-shot cures: https://arstechnica.com/tech-policy/2018/04/curing-disease-n...